The recent appointment of Fatima Zuntu as Director-General of the National Biosafety Management Agency (NBMA) has generated widespread debate across Nigeria’s scientific, regulatory, and policy communities, with stakeholders raising concerns about her qualifications and experience for the highly technical role.
Zuntu’s appointment, approved by Bola Ahmed Tinubu, is for a four-year term effective April 16. In an official statement, the Presidency described her as a public health professional and policy strategist, highlighting her academic background and experience in healthcare-related fields. However, the announcement has not gone without scrutiny, as critics question whether she meets the statutory requirements outlined in the NBMA Act of 2015.
The NBMA is a critical regulatory agency responsible for overseeing biotechnology and the use of Genetically Modified Organisms (GMOs) in Nigeria. Its mandate includes ensuring biosafety standards, protecting biodiversity, and safeguarding public health through scientific risk assessments and regulatory enforcement. Given the technical nature of these responsibilities, stakeholders argue that leadership of the agency requires deep expertise and extensive experience in biosafety or closely related disciplines.
Central to the controversy is the provision in the NBMA Act that stipulates that the Director-General must possess at least 15 years of cognate experience in biosafety, biodiversity, or related scientific fields. Critics contend that Zuntu’s publicly available professional history does not appear to meet this threshold, raising questions about the legality and appropriateness of her appointment.
Several officials within the agency, speaking anonymously, expressed concern over what they described as a pattern of leadership instability and questionable appointments. One senior official noted that the agency has struggled to maintain consistent leadership in recent years, which has affected its operational effectiveness and long-term planning.
“We’ve not been lucky at this agency with the appointment of Directors-General,” the official said, pointing to frequent leadership changes that have disrupted institutional continuity. Within the past three years alone, the NBMA has seen multiple heads, with previous appointees either resigning early or failing to complete their tenure.
Agnes Asagbra, who was appointed in 2023, did not complete her term, while Bello Bwari reportedly stepped down after only about six months in office. Observers say such rapid turnover at the top has created uncertainty within the agency and weakened its ability to deliver on its mandate effectively.
In addition to concerns about experience, some critics have questioned Zuntu’s age and career trajectory. One agency source remarked that she is relatively young and may lack the depth of expertise required to lead a national regulatory body of such importance. “This lady is just approaching 30 years old. She is not experienced at all. How do they want her to lead?” the source queried.
Public commentators have also weighed in on the issue. Tosin Arebuwa, a policy analyst, criticized what he described as a lack of professional depth in Zuntu’s career history. He noted that she has worked across multiple organizations within a relatively short period, raising concerns about the level of specialization needed for the role.
“In less than 10 years, she’s worked six different jobs across six different organisations. Where is the place of depth and expertise?” Arebuwa asked, emphasizing the importance of sustained experience in a specialized field like biosafety regulation.
Despite the criticism, supporters of the appointment argue that Zuntu brings a fresh perspective to the agency and possesses a multidisciplinary background that could enhance policy innovation. They point to her academic credentials, which include a medical degree from the University of Maiduguri and a master’s degree in public health from the University of South Wales, as evidence of her capacity to understand complex health and regulatory issues.
Proponents also suggest that leadership effectiveness is not solely determined by years of experience but by competence, vision, and the ability to mobilize teams and resources. They argue that younger professionals can bring energy, adaptability, and modern approaches to governance, particularly in areas that intersect with emerging technologies and global health challenges.
However, the debate has underscored broader concerns about governance and institutional integrity in Nigeria’s public sector. Analysts note that appointments to critical regulatory agencies must not only comply with legal requirements but also inspire confidence among stakeholders, including scientists, investors, and international partners.
The NBMA plays a pivotal role in Nigeria’s agricultural and technological development, particularly as the country explores the use of biotechnology to enhance food security and economic growth. Any perceived weakness in its leadership could have far-reaching implications for policy implementation, regulatory credibility, and public trust.
As the controversy continues, calls have emerged for greater transparency in the appointment process and stricter adherence to statutory provisions. Some stakeholders have urged the government to clarify the criteria used in selecting Zuntu and to provide assurances that the agency’s operations will not be compromised.
For now, the focus remains on how the new Director-General will navigate the challenges ahead. With heightened scrutiny from both within and outside the agency, Zuntu’s tenure is likely to be closely watched as a test of both her leadership capabilities and the government’s commitment to merit-based appointments.
The unfolding debate reflects a broader national conversation about competence, accountability, and the standards required to manage institutions that are central to Nigeria’s development trajectory.
